Benitec Biopharma Inc. (BNTC) NASDAQ

13.06

-0.04(-0.31%)

Updated at November 20 01:50PM

Currency In USD

Benitec Biopharma Inc.

Address

3940 Trust Way

Hayward, CA 94545

United States of America

Phone

510 780 0819

Sector

Healthcare

Industry

Biotechnology

Employees

16

First IPO Date

June 24, 2014

Key Executives

NameTitlePayYear Born
Dr. Jerel A. Banks M.D., Ph.D.Executive Chairman & Chief Executive Officer1.07M1975
Dr. Michael GrahamHead of Discovery & Founding Scientist125,881N/A
Ms. Megan Joan Boston B.Com., C.A.Chief Financial Officer, Secretary & Director870,8131972
Ms. Sophie MukadamChief Operating Officer940,4391981
Dr. Claudia Kloth Ph.D.Senior Vice President of Manufacturing0N/A

Description

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.